Why Nutrien Stock Jumped 55% in 2021

Nutrien (TSX:NTR)(NYSE:NTR) had a stellar year for 2021, and while 2022 may slow, expect great things from this stock for long-term investors.

| More on:
analyze data

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s premium investing services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn moresdf

Nutrien (TSX:NTR)(NYSE:NTR) managed to be one of the few Canadian stocks to soar during 2021. While others climbed and fell, Nutrien remained on a steady streak upwards. It now trades at all-time highs, currently at $95 per share. That’s a 55% increase in 2021 alone.

But what about 2022? Are the reasons the company soared last year likely to continue this year as well? Let’s take a look.

An essential service

No matter what happens in the world, people need to eat. And when the world is being affected by a pandemic, floods, mudslides, and other disasters, that need also doesn’t go away. That’s why crop nutrient provider Nutrien has remained a strong player, even during this last year.

The company is now the world’s largest producer of potash, which farmers use to boost their crop yields. Nutrien was already a strong company for Motley Fool investors to consider even before the pandemic. This came from major partnerships with highly populated countries like India and China needing crop nutrients and seeking out Nutrien.

This is the case everywhere. The company could have seen competitors edge in on profits during the pandemic, but instead, it entered the digital age and saw its e-commerce arm explode. This will help it remain a strong producer, with stockpiles that will continue driving potash demand well into 2022.

Long-term defence

If you’re a long-term Motley Fool investor, Nutrien proved in the last year why you want it in your corner. The company managed to hit record earnings in the third quarter and the first nine months of the year during it latest report. Further, it raised its full-year guidance for 2021. It now expects between US$6.9 and US$7.1 billion, up from between US$6.0 and US$6.4 billion. Meanwhile, net earnings jumped by over a dollar to between US$5.85 and US$6.10.

And don’t think this will suddenly disappear. Even if you ignore the increasing demand for Nutrien as a whole, the company also has a strong balance sheet. This has allowed it to become an acquisition powerhouse. The company has seen major organic and acquisition growth over the last few years, cornering the market through these means. And that is likely to continue for the foreseeable future.

All this growth is likely to mean one thing: a dividend increase. Nutrien already offers a 2.47% dividend yield. However, given its strong performance during the pandemic and likely strength in 2022, Motley Fool investors could see a big jump in 2022. This could be coupled by a share-buyback program, as the company already repurchased 2.4 million shares last quarter.

Foolish takeaway

Commodity prices continue to climb as inflation rises. Farmers now enjoy above-average profits from the increase in value of their crops. This makes Nutrien’s crop nutrients a necessity for consumers and farmers alike, to keep cash coming in for everyone.

And I do mean everyone. That includes Motley Fool investors seeking out a defensive stock that will bring in returns and dividends for decades. Nutrien is that stock. Enjoy a 2.47% dividend yield, 55% in returns, and (somehow) a valuable share price trading at 18.95 times earnings.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Amy Legate-Wolfe has no position in any of the stocks mentioned. The Motley Fool recommends Nutrien Ltd.

More on Coronavirus

little girl in pilot costume playing and dreaming of flying over the sky
Coronavirus

Air Canada Stock: How High Could it go?

AC stock is up 29% in the last six months alone, so should we expect more great things? Or is…

Read more »

eat food
Coronavirus

Goodfood Stock Doubles Within Days: Time to Buy?

Goodfood (TSX:FOOD) stock has surged 125% in the last few weeks, so what happened, and should investors hop back on…

Read more »

stock data
Tech Stocks

If I Could Only Buy 1 Stock Before 2023, This Would Be It

This stock is the one company that really doesn't deserve its ultra-low share price, so I'll definitely pick it up…

Read more »

Aircraft Mechanic checking jet engine of the airplane
Coronavirus

Air Canada Stock Fell 5% in November: Is it a Buy Today?

Air Canada (TSX:AC) stock saw remarkable improvements during its last quarter but still dropped 5% with more recession hints. So,…

Read more »

Airport and plane
Coronavirus

Is Air Canada Stock a Buy Today?

Airlines are on the rebound. Does Air Canada stock deserve to be on your buy list?

Read more »

A patient takes medicine out of a daily pill box.
Coronavirus

Retirees: 2 Healthcare Stocks That Could Help Set You up for Life

Healthcare stocks offer an incredible opportunity for growth for those investors who look to the right stocks, such as these…

Read more »

sad concerned deep in thought
Coronavirus

Here’s Why I Just Bought WELL Health Stock

WELL Health stock (TSX:WELL) may be a healthcare stock and a tech stock, but don't let that keep you from…

Read more »

healthcare pharma
Coronavirus

WELL Stock: The Safe Stock Investors Can’t Afford to Ignore

WELL stock (TSX:WELL) fell 68% from peak to trough, and yet there's no good reason as to why. So now…

Read more »